Mitsubhishi Tanabe Pharma's ALS drug treats more than 1000 people in three months

Japan’s Mitsubishi Tanabe Pharma America, Inc. today announced that more than 1,000 people with amyotrophic latera...

November 17, 2017 | Friday | News
Seres Therapeutics, MD Anderson Cancer Center and Parker Institute for Cancer Immunotherapy collaborates

Seres Therapeutics, The University of Texas MD Anderson Cancer Center (MD Anderson), and the Parker Institute ...

November 15, 2017 | Wednesday | News
Bayer and Loxo Oncology to develop and commercialize two novel oncology therapies

Life Science company Bayer has entered into an exclusive global collaboration with US based biopharma company Loxo Oncol...

November 15, 2017 | Wednesday | News
Korea's Dongsung Pharmaceuticals opens a new cancer research center in Seoul

In a bid to further strengthen its pipeline of cancer treatments, Korea’s Dongsung Pharmaceuticals has recently op...

November 14, 2017 | Tuesday | News
Helperby Therapeutics develops sustainable solution for antibiotic resistance

UK based pharma company, Helperby Therapeutics has developed Antibiotic Resistance Breakers (ARBs) as a solution to the ...

November 13, 2017 | Monday | News
Amgen And Novartis announce expanded collaboration with Banner Alzheimer's Institute

Singapore – Amgen and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to ...

November 3, 2017 | Friday | News
Boehringer Ingelheim and Dicerna collaborate to develop treatments for chronic liver diseases

Pharma company Boehringer Ingelheim and leading developer of RNAi therapeutics Dicerna Pharmaceuticals has announced a r...

November 2, 2017 | Thursday | News
Evolution of drug delivery system for better patient safety

Chronic conditions such as diabetes, multiple sclerosis and rheumatoid arthritis are on the rise and often require daily...

November 1, 2017 | Wednesday | News
CFDA accepts Eisai's NDA for cancer drug

 Eisai Co., Ltd. announced that the China Food and Drug Administration (CFDA) has accepted for review a New Drug Ap...

October 31, 2017 | Tuesday | News
New 'Double Decker' Antibody Technology Fights Cancer 

Singapore - Scientists from the Florida campus of The Scripps Research Institute (TSRI) have created...

October 26, 2017 | Thursday | News
Alopexx completes first-in-man trial of its novel, broad-spectrum anti-microbial vaccine 

Singapore - Alopexx Vaccine LLC (a US- based science driven investment company) announced that it has completed a Phase ...

October 26, 2017 | Thursday | News
Incyte and MacroGenics collaborates for anti-PD-1 monoclonal antibody

Biopharma company, Incyte Corporation and MacroGenics has announced that the companies have entered into an exclusi...

October 26, 2017 | Thursday | News
AbbVie plows $205M upfront Into Alector's Alzheimer's Program

AbbVie announced a strategic collaboration with South San Francisco-based Alector to develop and commercialize drugs for...

October 25, 2017 | Wednesday | News
Eisai, Biogen expand their agreement to codevelop and commercialize AD drug

  Japan’s Eisai and US based Biogen announced the expansion  of their existing collaboration agreement ...

October 24, 2017 | Tuesday | News
“With the new blood testing technology, the laboratories can better focus their resources and expertise.”

Q. Can you briefly explain this new blood testing technology and how is it different from the more conventional tests th...

October 13, 2017 | Friday | Opinion
Novel bi-specific antibody shows strong therapeutic potential to treat Zika virus infection

Singapore - The Journal Cell published data with a bi-specific antibody against Zika virus infection. The article is ent...

October 12, 2017 | Thursday | News
Adult patients with Schizophrenia in Singapore to benefit from the first three-monthly long-acting treatment

Singapore – Johnson & Johnson (J&J) announced the launch of its three-monthly long-acting treatment for sc...

October 10, 2017 | Tuesday | News
Chiome Bioscience selects ProBioGen for GlymaxX antibody manufacturing program

ProBioGen AG, a premier service & technology provider for complex therapeutic glycoproteins and Chiome Bioscience In...

October 5, 2017 | Thursday | News